SABS (SAB Biotherapeutics Inc) Gross Profitability

Official company branding of SAB Biotherapeutics, Inc (SABS)

SAB Biotherapeutics is investing in transgenic animals to create a high-yield treatment system. Gross sales margins demonstrate operational efficiency, where 0.00 reflects the latest metric value. The human antibody production platform under development is easily scalable for the global market. The company's current growth relies on innovative methods for combating type 1 diabetes and viral threats.

SABS (sabbiotherapeutics.com) Gross Margin history from 07/04/2022 to 11/20/2026

Analytical breakdowns and data insights for company SAB Biotherapeutics Inc. (SABS)

Summary company analysis:SAB Biotherapeutics, Inc. - SABS
Mass-produced product of SAB Biotherapeutics, Inc.

For SAB Biotherapeutics (SABS), the efficiency of producing unique antibodies becomes a key factor amid the fierce struggle with biotech behemoths for investment. This metric measures the share of revenue minus direct production costs, allowing the company to assess the resilience of its business model to rising costs through gross profit margins and determine the company's actual margin of safety in the face of competition.

Direct competitors

argenx - Gross Profit Rate|Gross Profitability biontech.de|ABIVAX (ABVX) - Return on Sales by Gross Profit|Gross Margin ADMA|Gross Profit Ratio PTGX|Gross Profitability Immunovant Corp IMVT|Gross Margin Kiniksa Pharmaceuticals, Ltd. KNSA|GRFS - Gross Profitability|Return on Sales by Gross Profit Adaptive Biotechnologies ADPT|CLDX (Celldex Therapeutics, Inc.) - Return on Gross Profit|Aurinia Pharmaceuticals Inc. (AUPH) - Gross Margin|Return on Gross Profit BCRX|Gross Profit Margin Vera Therapeutics Inc VERA|Return on Gross Profit DNTH (Dianthus Pharma)|Return on Sales by Gross Profit Pharvaris N.V.|AbCellera Biologics Inc - Return on Gross Profit|Tourmaline Bio (TRML) - Gross Profit Margin|PGEN - Gross Profitability|Gross Profit Rate PHAR (Pharming Group NV)|NKTR: Gross Margin|Upstream Bio Corp - Gross Profit Rate|Gross Profitability Zenas Biopharma Inc|Immunome, Inc. (IMNM) - Return on Sales by Gross Profit|Gross Margin GOSS|Return on Gross Profit KalVista Pharmaceuticals, Inc. KALV|Gross Profitability Septerna SEPN|Pieris Pharmaceuticals (PVLA) - Gross Profit Margin|SVRA - Gross Profitability|Rigel Pharmaceuticals - Gross Profit Ratio|AnaptysBio Corp (ANAB) - Gross Profitability|ATXS - Return on Sales by Gross Profit|Gross Profitability enGene Holdings Inc.|RAPT: Gross Profit Rate|Gross Margin JBIO|Return on Gross Profit aclaristx.com ACRS|Gross Profitability Kyverna Therapeutics Inc. KYTX|Tiziana Life Sciences Ltd. (TLSA) - Gross Profit Margin|Cabaletta Bio, Inc - Gross Margin|Gross Profit Margin Ventyx Biosciences|THTX (theratech.com) - Return on Gross Profit|Return on Gross Profit Avalo Therapeutics, Inc|ELDN (Eledon Pharmaceuticals, Inc) - Gross Margin|Gross Profit Margin Agenus Inc. AGEN|Return on Gross Profit CLYM (Climb Bio, Inc.)|ZURA (Zura Bio Ltd) - Gross Profit Rate|Gross Profitability atyrpharma.com ATYR|Gross Margin Adagene Corp ADAG|IMA - Gross Profitability|Gross Profit Rate STTK (Shattuck Labs)|EQ: Gross Margin|Connect Biopharma (CNTB) - Gross Margin|Gross Profitability Immunic|Gross Margin atarabio.com|Gross Margin IFRX|Gross Margin X4 Pharma (XFOR)|Gross Margin ACET (adicetbio.com)|Gross Margin Celularity Inc. CELU|INMB - Gross Profitability|Gross Profit Rate BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Return on Gross Profit|Return on Gross Profit Akari Therapeutics plc|Gross Profitability enlivex.com|q32bio.com (QTTB) - Return on Sales by Gross Profit|Gross Margin GOVX|Edesa Biotech, Inc. - Gross Return on Sales|iBio Inc - Return on Gross Profit|Gross Margin Carisma Therapeutics CARM|XTLB - Gross Profitability|BOLT (boltbio.com) - Gross Return on Sales|HCWB: Gross Margin|Aptevo (APVO) - Gross Margin|Gross Profitability AIM ImmunoTech|Return on Gross Profit Aditxt (ADTX)|Return on Gross Profit GRI (GRI Bio Corporation)|XORTX - Gross Return on Sales|Gross Margin HIND (Vyome Holdings Inc.)|Gross Profit Rate REVB|Indaptus - Gross Margin|SCNI (Scinai Immunotherapeutics Ltd.) - Gross Return on Sales|CALI: Gross Margin|Affimed NV - Gross Profit Rate|Gross Profitability Allakos Inc.|Gross Margin HOOKIPA Pharma|Gross Profitability IGM Biosciences, Inc. (IGMS)|ITOS - Gross Profit Margin|Gross Margin OCEA (Ocean Bio)|Gross Profit Rate TCBP|THRD - Gross Profitability